PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Astronomers discover new Earth-sized world orbiting an ultra-cool star

2024-05-15
(Press-News.org) A new, Earth-sized planet orbiting an ultra-cool red dwarf star, has been detected by an international team of astronomers – just 55 light years away. 

The planet is only the second of its kind to be discovered around this type of star. Called SPECULOOS-3 b, it takes around 17 hours to complete an orbit of the star which is more than twice as cold as our sun, as well as ten times less massive and a hundred times less luminous. 

Days and nights on SPECULOOS-3 b seem to be endless: the planet is likely to be tidally locked, so the same side – the ‘dayside’ – always faces the star in a relationship similar to our moon and Earth.   

The discovery, published today (15 May 2024) in Nature Astronomy, was made by the SPECULOOS project, which is led by the University of Liège, in Belgium, in collaboration with the Universities of Birmingham, Cambridge, Bern, and the Massachusetts Institute of Technology. SPECULOOS (Search for Planets EClipsing ULtra-cOOl Stars) was established to search for exoplanets orbiting ultra-cool dwarf stars using a network of robotic telescopes based around the world. 

Ultra-cool dwarf stars are extremely common, making up around 70% of the stars in the Milky Way. But they are also very faint and scattered across the sky, so scientists have to observe data from telescopes over several weeks, monitoring each star individually to detect transiting planets.  

“We designed SPECULOOS specifically to observe nearby ultracool dwarf stars in search of rocky planets that lend themselves well to detailed studies," says Michaël Gillon, astronomer at the University of Liège and lead author on the paper. "In 2017, our SPECULOOS prototype using the TRAPPIST telescope discovered the famous TRAPPIST-1 system made up of seven Earth-sized planets, several of them potentially habitable. This was an excellent start!” 

Whilst most observations of  this discovery were made by SPECULOOS telescopes in the Northern Hemisphere, the University of Birmingham researchers contributed some observations taken at the SPECULOOS South Observatory, located in the Atacama Desert in Chile.  

Amaury Triaud, Professor of Exoplanetology at the University of Birmingham said: “The discovery of SPECULOOS-3 shows our worldwide network functions well and is ready to detect yet more rocky worlds orbiting very low mass stars While ultra-cool dwarf stars are cooler and smaller than our sun, their lifespan is over a hundred times longer – around 100 billion years – and they are expected to be the last stars still shining in the Universe.”  

This long life span, scientists believe, could offer opportunities for life on orbiting planets to develop.  

Whilst most astronomical data is automatically analysed and planetary candidates are often first detected by algorithms before being reviewed by humans, in this case, this did not happen. Members of the SPECULOOS team had taken the habit to quickly glance at the nightly data when they became available, and Dr Georgina Dransfield, a former PhD student at the University of Birmingham and a current postdoctoral researcher in Birmingham noticed the planetary signal and alerted the whole collaboration.  

She said: “The small size of ultra-cool dwarfs makes it easier to detect small planets. SPECULOOS-3b is special in that its stellar and planetary properties make it an optimal target for JWST, which is capable to get information about the composition of the rocks that make its surface.” 

Next steps for the project could include follow-up observations by the James Webb Space Telescope, which would deliver important insights into the planet’s surface mineralogy, and the potential for an atmosphere. 

END


ELSE PRESS RELEASES FROM THIS DATE:

New biomarker to diagnose Alzheimer's in asymptomatic stages

New biomarker to diagnose Alzheimers in asymptomatic stages
2024-05-15
A recent study led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona has identified a new biomarker for Alzheimer's disease in asymptomatic stages of the disease. The molecule is miR-519a-3p, a microRNA directly linked to the expression of the cellular prion protein (PrPC), which is deregulated in people suffering from some neurodegenerative diseases such as Alzheimer's. The search for biomarkers that are stable and easily detectable in biofluids, ...

Research sheds light on how proteins linked to Alzheimer’s disease influence neuronal growth

2024-05-15
New research has shed light in the complex interplay between cell proteins, and how they impact on neurons in neurodevelopmental disorders and Alzheimer’s disease. A new study led by the University of Exeter and published in Royal Society Open Biology has discovered the key role that the protein Contactin-4 (encoded by the gene CNTN4) plays in shaping neurons. The researchers began studying CNTN4 because it was known to have a role in autism, but its functional roles were not well understood. The team explored how CNTN4 functions within the brain, particularly its interactions with proteins involved in neurodegenerative diseases like Alzheimer's ...

Early retirement of old vehicles won't save the planet: A study

Early retirement of old vehicles wont save the planet: A study
2024-05-15
Lifespan caps for passenger vehicles have limited effect on reducing greenhouse gas emissions and could drive up costs and material use finds a new study published in Environmental Research: Infrastructure and Sustainability. The research shows that although Light-Duty vehicles (LDVs) contribute 17% to the annual greenhouse gas emissions in the United States, imposing a 15-year lifespan cap on LDV fleets under a business-as-usual scenario will not lead to any meaningful reductions in GHG emissions.  To combat delayed uptake of Electric Vehicles (EVs), some have argued for limits on the vehicle’s ...

EuroPCR 2024 – Short-term data from NOTION-2: TAVR versus SAVI for younger patients with aortic stenosis

2024-05-15
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.  Among them is the NOTION-2 randomised clinical trial (RCT).  Background   Evidence comparing the use of transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) in low-risk patients with aortic ...

EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

2024-05-15
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice. Among them is the REC-CAGEFREE II trial.  Background and methods  The REC-CAGEFREE II trial is an open-label, investigator-initiated, non-inferiority, multicentre randomised trial comparing stepwise de-escalation of dual antiplatelet therapy (DAPT) with standard DAPT in patients with acute coronary syndrome (ACS) treated with paclitaxel-coated balloons (PCB). Eligible ...

EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

2024-05-15
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.  Among them is the LANDMARK trial. Background and Methods  Key randomized controlled trials have compared surgical aortic valve replacement (SAVR) with transcatheter aortic valve implantation (TAVI) using one of two commercially available transcatheter heart valves (THVs) - ...

How does exercise benefit the brain?

2024-05-15
New research published in Aging Cell provides insights into how exercise may help to prevent or slow cognitive decline during aging. For the study, investigators assessed the expression of genes in individual cells in the brains of mice. The team found that exercise has a significant impact on gene expression in microglia, the immune cells of the central nervous system that support brain function. Specifically, the group found that exercise reverts the gene expression patterns of aged microglia to patterns seen in young microglia. Treatments that depleted ...

How will climate change affect the distribution of jellyfish and other gelatinous zooplankton in the Arctic Ocean?

2024-05-15
Gelatinous zooplankton, including jellyfish and other diverse, nearly transparent organisms, play important roles in marine ecosystems. Climate change is expected to significantly alter their populations and distributions. New research published in Limnology and Oceanography examines their fate in the Arctic Ocean, one of the fastest warming oceans on Earth. Investigators coupled three-dimensional species distribution models with oceanographic variables from the Coupled Model Intercomparison Project Phase 6. The analyses allowed the team to identify gelatinous ...

Researchers identify new marker for breast cancer prognosis

2024-05-15
A protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and mutations in the RPGRIP1L gene have been linked to different diseases. New research published in The FASEB Journal indicates that expression levels of the RPGRIP1L gene might serve as a new prognostic marker for individuals with invasive breast cancer. When investigators examined breast tissue specimens from different women, they found that the ...

Can robot-inspired computer-assisted therapy benefit children with autism?

2024-05-15
A new study published in the Journal of Computer Assisted Learning introduces a novel Robot-Inspired Computer-Assisted Adaptive Autism Therapy (RoboCA3T) that leverages the natural affinity of children with autism spectrum disorder towards technology and robots. RoboCA3T harnesses the potential of robot-assisted therapies by incorporating robot avatars and integrating them with computer-assisted therapies through a web-based solution. When investigators assessed Childhood Autism Rating Scale scores before and after the intervention, ...

LAST 30 PRESS RELEASES:

Heart rate changes predict depression treatment success with magnetic brain stimulation

Genetics pioneer transforms global depression research through multi-omics discoveries

MDMA psychiatric applications synthesized: Comprehensive review examines PTSD treatment and emerging therapeutic indications

Psychedelics offer new therapeutic framework for stress-related psychiatric disorders

Brain cell discoveries reshape understanding of psychiatric disorders

Mom’s voice boosts language-center development in preemies’ brains, study finds

Development of silicon ultrasound patch achieves both eco-friendliness and performance enhancement

Measles immunity 90% in BC’s Lower Mainland

Women’s brain regions may lose ability to synchronize after sexual assault

Quitting smoking, even late in life, linked to slower cognitive decline

Critical raw materials are a vital new currency; Europe’s e-waste is the vault

Anesthesiologist-led care helps hip-fracture patients get to surgery faster, with fewer complications

Two-dose recombinant shingles vaccine is effective even accounting for prior receipt of live shingles vaccine

Excessive daytime sleepiness may raise risk of cognitive problems after surgery

Flipping the switch on sperm motility offers new hope for male infertility

Twisting sound: Scientists discover a new way to control mechanical vibrations in metamaterial

Drip by drip: The hidden blueprint for stalagmite growth

mRNA therapy restores sperm production and fertility in mice

New way to weaken cancer cells could supercharge prostate cancer treatment

How sound—but not touch—shapes rhythm in the brain

Exploring the therapeutic potential of hypothermia

Research alert: Bioengineering breathes new life into failed cancer treatment

AI, health, and health care today and tomorrow – the JAMA Summit Report on artificial intelligence

Large genetic study links cannabis use to psychiatric, cognitive and physical health

Social media use trajectories and cognitive performance in adolescents

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults 

AI models predict sepsis in children, allow preemptive care

Liraglutide vs semaglutide vs dulaglutide in veterans with type 2 diabetes

Antenatal corticosteroids and infectious diseases throughout childhood

New lab-grown human embryo model produces blood cells

[Press-News.org] Astronomers discover new Earth-sized world orbiting an ultra-cool star